These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2441526)

  • 1. [Use of beta-endorphin in pain in cancer patients].
    González-Navarro A; Zimman Mansfeld H; Molinero Aparicio T; González Hernandez MJ; González Maté A; Borque-Ibarra M
    Vopr Onkol; 1987; 33(7):26-32. PubMed ID: 2441526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analgesic effect of continuous intrathecal beta-endorphin in cancer patients].
    Jin T; Murakawa T; Oyama T
    Masui; 1986 Jan; 35(1):148-51. PubMed ID: 2940384
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic activity of beta-endorphin in man.
    Catlin DH; Hui KK; Loh HH; Li CH
    Commun Psychopharmacol; 1977; 1(5):493-500. PubMed ID: 606482
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levels of 5-HIAA and beta-endorphin in CSF after intrathecal morphine].
    González Navarro A; Zimman Mansfeld H; Ortiz-González JM; Molinero Aparicio T; González Hernández MJ; Ferrero Fernandez B
    Arch Neurobiol (Madr); 1985; 48(4):211-3. PubMed ID: 2416296
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain.
    Max MB; Inturrisi CE; Kaiko RF; Grabinski PY; Li CH; Foley KM
    Clin Pharmacol Ther; 1985 Dec; 38(6):631-41. PubMed ID: 2415286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patients.
    Johansson F; von Knorring L; Sedvall G; Terenius L
    Psychiatry Res; 1980 May; 2(2):167-72. PubMed ID: 6158065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal administration of beta-endorphin and dynorphin-(1-13) for the treatment of intractable pain.
    Wen HL; Mehal ZD; Ong BH; Ho WK; Wen DY
    Life Sci; 1985 Sep; 37(13):1213-20. PubMed ID: 2864619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thalamic relay nucleus stimulation for relief of intractable pain. Clinical results and beta-endorphin immunoreactivity in cerebrospinal fluid].
    Tsubokawa T; Yamamoto T; Katayama Y; Nishimoto H; Hirayama A; Shibuya H
    No Shinkei Geka; 1984 Mar; 12(4):459-67. PubMed ID: 6330600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-endorphin in the plasma and cerebro-spinal fluid during different types of analgesia in early postoperative period and in incurable cancer patients].
    Pavlova ZV; Laktionov KP; Isakova ME; Kushlinskiĭ NE
    Biull Eksp Biol Med; 1999 Nov; 128(11):565-70. PubMed ID: 10640249
    [No Abstract]   [Full Text] [Related]  

  • 10. Profound analgesic effects of beta-endorphin in man.
    Oyama T; Jin T; Yamaya R; Ling N; Guillemin R
    Lancet; 1980 Jan; 1(8160):122-4. PubMed ID: 6101459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C; Brunelli C
    J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pain and opioid peptides].
    Oyama T
    Nihon Rinsho; 1984 Apr; 42(4):907-12. PubMed ID: 6090729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the beta-endorphin plasma levels caused by epidural morphine analgesia during the early postoperative period in cancer patients].
    Bassalyk LS; Pavlova ZV; Sidorkin VA; Kushlinskiĭ NE; Isakova ME
    Anesteziol Reanimatol; 1986; (1):20-4. PubMed ID: 2938526
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of intraventricular and intrathecal morphine in intractable pain associated with cancer.
    Nurchi G
    Neurosurgery; 1984 Dec; 15(6):801-3. PubMed ID: 6549051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cancer-related pain with transdermal fentanyl.
    Leelanuntakit S
    J Med Assoc Thai; 1996 Jun; 79(6):341-6. PubMed ID: 8855606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal morphine for cancer pain control.
    Parker GA; Fell DA; Young JA
    J Okla State Med Assoc; 1987 Dec; 80(12):849-52. PubMed ID: 2448436
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of intrathecal bupivacaine: how important is the flow rate?
    Buchser E; Durrer A; Chédel D; Mustaki JP
    Pain Med; 2004 Sep; 5(3):248-52. PubMed ID: 15367302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy for pain in cancer patients].
    Schreml W; Merkle W; Heimpel H
    Med Klin; 1981 Jan; 76(2):43-7. PubMed ID: 6111742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.